46 min listen
Unavailable
ratings:
Length:
135 minutes
Released:
May 31, 2020
Format:
Podcast episode
Description
Daniel Griffin provides a clinical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, reducing viral transmission, and much more, including listener email. Show notes coming soon.
Released:
May 31, 2020
Format:
Podcast episode
Titles in the series (100)
TWiV 1074: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses the outcomes of SARS-CoV-2, influenza and respiratory syncytial virus infection in pediatric communities under the age of 18 years, the treatment of infants with the human monoclonal... by This Week in Virology